US Bancorp DE Lowers Stock Holdings in Azenta, Inc. (NASDAQ:AZTA)

US Bancorp DE trimmed its position in shares of Azenta, Inc. (NASDAQ:AZTA) by 52.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,381 shares of the company’s stock after selling 4,782 shares during the quarter. US Bancorp DE’s holdings in Azenta were worth $219,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of AZTA. State of New Jersey Common Pension Fund D boosted its holdings in Azenta by 9.5% during the 3rd quarter. State of New Jersey Common Pension Fund D now owns 40,008 shares of the company’s stock valued at $1,938,000 after acquiring an additional 3,469 shares during the period. Entropy Technologies LP boosted its holdings in Azenta by 236.7% during the 3rd quarter. Entropy Technologies LP now owns 13,085 shares of the company’s stock valued at $634,000 after acquiring an additional 9,199 shares during the period. Aigen Investment Management LP purchased a new position in Azenta during the 3rd quarter valued at about $214,000. Victory Capital Management Inc. raised its position in Azenta by 4.0% in the 3rd quarter. Victory Capital Management Inc. now owns 27,281 shares of the company’s stock valued at $1,321,000 after purchasing an additional 1,061 shares in the last quarter. Finally, Zions Bancorporation N.A. raised its position in Azenta by 20.4% in the 3rd quarter. Zions Bancorporation N.A. now owns 23,904 shares of the company’s stock valued at $1,158,000 after purchasing an additional 4,057 shares in the last quarter. 99.08% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have issued reports on AZTA shares. Needham & Company LLC increased their price target on Azenta from $55.00 to $59.00 and gave the company a “buy” rating in a research report on Thursday, February 6th. Evercore ISI increased their price target on Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a research report on Thursday, February 6th. Stephens reissued an “overweight” rating and set a $60.00 target price on shares of Azenta in a research report on Thursday, January 2nd. Finally, TD Cowen raised Azenta to a “hold” rating in a research report on Thursday, February 27th. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat, Azenta presently has an average rating of “Hold” and an average target price of $58.75.

Azenta Stock Performance

Shares of NASDAQ AZTA opened at $36.80 on Friday. The stock’s 50-day simple moving average is $48.43 and its 200-day simple moving average is $47.15. The firm has a market capitalization of $1.68 billion, a PE ratio of -12.35 and a beta of 1.52. Azenta, Inc. has a fifty-two week low of $35.90 and a fifty-two week high of $63.58.

Azenta (NASDAQ:AZTA) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. On average, sell-side analysts forecast that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.